ImmunityBio
IBRX
#4122
Rank
HK$21.78 B
Marketcap
HK$22.12
Share price
9.46%
Change (1 day)
14.55%
Change (1 year)

Market capitalization of ImmunityBio (IBRX)

Market cap: HK$21.78 Billion

As of January 2026 ImmunityBio has a market cap of HK$21.78 Billion. This makes ImmunityBio the world's 4122th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of ImmunityBio from 2021 to 2026

End of year Market Cap

Year Marketcap Change
2026HK$21.78 B32.84%
2025HK$16.40 B4.07%
2024HK$15.75 B-39.8%
2023HK$26.17 B65.09%
2022HK$15.85 B-15.92%
2021HK$18.85 B

End of Day market cap according to different sources

On Jan 12th, 2026 the market cap of ImmunityBio was reported to be:

HK$19.90 Billion
by Nasdaq info icon info icon
HK$19.90 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
ORIC Pharmaceuticals
ORIC
HK$7.15 B-67.15%๐Ÿ‡บ๐Ÿ‡ธ USA